AGGRENOX Reduces Stroke Risk
You'll be glad to know that AGGRENOX helps reduce the risk of stroke in patients who had a TIA or stroke due to a blood clot. But you may be wondering—how does it work?
Blood clots: The cause of most strokes
In most cases, a stroke occurs when a blood clot blocks a blood vessel and cuts off the blood supply, along with oxygen and nutrients it carries, to a part of the brain. Blood clots form when certain blood cells, called platelets, clump together. This type of stroke is known as an ischemic stroke.
When this happens, blood cannot get through to a section of the brain, so that part of the brain's oxygen supply is cut off. Within minutes, those brain cells die and abilities controlled by those cells are lost. A TIA is a brief episode of stroke-like symptoms, with no lasting brain cell damage.
This is why your doctor may have prescribed AGGRENOX—to reduce the likelihood that you will have a blood clot that can cause a stroke.
AGGRENOX works by combining 2 medications
AGGRENOX combines 2 medications—aspirin and extended-release dipyridamole. Both medications are known as antiplatelet agents.
Platelets are cells in your blood that stick together to help your blood clot. Antiplatelet agents work together to make platelets in the blood less sticky. That means they're less likely to clump together and form blood clots–the cause of 87% of strokes.
Together, the 2 antiplatelet agents in AGGRENOX work better than either medication alone at reducing the risk of a future stroke. In fact, in a clinical study:
- Over 90% of patients taking AGGRENOX remained stroke-free for 2 years (1493 patients out of a total of 1650).
- Patients taking AGGRENOX twice daily were 22% less likely to have a stroke than patients taking low-dose aspirin (25 mg twice daily) alone.
- AGGRENOX was twice as effective as low-dose aspirin (25 mg twice daily) at reducing the risk of a subsequent stroke when tested against a sugar pill.
Next: Talking With Your Doctor
Learn about AGGRENOX
Find out how many patients in a clinical study remained stroke-free over 2 years.learn more
Stroke and TIA Stories
Find out how others are reducing
their risk of a
The Taking Smart Steps™ program
Get free tips, tools, and information to help you stay on track with your treatment.Enroll Now
for your next
Create a personalized doctor discussion guide to capture your questions
Insights for caregivers
Caring for someone after a stroke can be difficult.Get info and advice that may help
Savings and support
Find out about savings on AGGRENOX and FREE support programs.learn more
Insight for caregivers
Get information tailored to those who are caring for someone who has experienced a stroke or TIA.learn more
Learn more about stroke and what you can do to reduce your risk with these resources.learn more
Door to Door Terms and Conditions
Patients must have a valid prescription for AGGRENOX.
By enrolling, I elect to receive the branded product and acknowledge that no generic substitution will be offered (if applicable). Should I wish to receive a generic product in the future, I will call 1-855-892-3438 to opt out of this program.
Patients without insurance restrictions and co-pays of $100 or less will pay a $0 co-pay for a one-month supply of AGGRENOX. For patients whose co-pay is between $100 and $135, they will pay that amount minus the maximum savings benefit of $100 per month. No one will pay more than $35. Patients with insurance restrictions or co-pays of more than $135, they will not be processed through insurance and will pay $35 for a one-month supply (60 capsules) of AGGRENOX.
If you have Medicare Part D, Medicaid or a similar state or federally funded medical assistance program, you will pay a cash price of $35 for a one-month supply of AGGRENOX. All Medicare Part D orders are processed without the use of insurance and cannot be applied to Part D true out of pocket (TrOOP) costs. Taxes may apply.
Boehringer Ingelheim Pharmaceuticals, Inc. retains the right to rescind, revoke, or amend this offer at any time without notice.